The HERBERT study evaluated a high-dose-rate endorectal brachytherapy boost (HDREBT) after EBRT in medically inoperable/elderly patients with rectal cancer. The response-rates are promising but not without risk of toxicity. The current analysis provides a comprehensive overview of patient reported, physician reported and endoscopically observed toxicity.
from Imaging via alkiviadis.1961 on Inoreader http://ift.tt/2nBLEaY
Παρασκευή 2 Φεβρουαρίου 2018
Evaluation of clinical and endoscopic toxicity after external beam radiotherapy and endorectal brachytherapy in elderly patients with rectal cancer treated in the HERBERT study
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
A study using a new computer-aided detection (CAD) algorithm found breast cancers... Read more on AuntMinnieEurope.com Related Reading: ...
-
Predictors of postoperative pneumonia in patients undergoing oral cancer resections and its management p. 69 Ridhi Sood, Jerry Paul, Sunil... -
This work presents the nonlinear dynamical analysis of a multilayer piezoelectric macrofiber composite (MFC) laminated shell. The effects of...
-
Dicyclohexyl phthalate (DCHP) is one of the phthalate plasticizers. The objective of the present study was to investigate the effects of DCH...
-
This study proposes an improved metabolism grey model [IMGM] to predict small samples with a singular datum, which is a common phenomenon in...
-
<span class="paragraphSection">Much public health research seeks to identify harm and then use that knowledge as the basis f...
-
Most prescribers and patients in Ghana now opt for the relatively expensive artemether/lumefantrine rather than artesunate-amodiaquine due t...
-
Antineutrophil cytoplasmic antibody- (ANCA-) associated vasculitis (AAV) is a multisystem autoimmune disease affecting mainly microscopic bl...
-
The Nephroprotective Effect of Mannitol in Head and Neck Cancer Patients Receiving Cisplatin Therapy Show all authors Erik Hägerström, Lotte...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου